New topical treatment for female pattern hair loss
Part of Skin clinical trials.
This study tests a new medicine (N1087) to see if it helps women with female pattern hair loss. It compares the study drug to a placebo (a dummy product) to check how well it works and if it's safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 60.
- You have mild to moderate female pattern hair loss (thinning on the top of the scalp).
- You have not used specific hair-loss treatments in the last 6 months, or you are willing to stop and wait 3 months before starting the study.
- You can get a small permanent tattoo on your scalp and have a small area shaved for measurements.
- You must keep the same hairstyle, hair color, and hair products throughout the study.
- You are not pregnant or breastfeeding and agree to use birth control during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment for female pattern hair loss in women aged 18 to 50. It aims to see if the treatment is safe and effective for regrowing hair.
This trial tests a new treatment for male pattern baldness (androgenic alopecia). It is for men with a moderate level of hair loss who have not used any hair loss treatments in the last 90 days.
This study tests two new topical treatments for hereditary hair loss. It may help you regrow hair or slow further thinning.
This study tests an experimental treatment using a substance made from your own hair follicles to see if it can help regrow hair in people with pattern baldness. It involves getting several small injections into your scalp over time.
This study compares two types of laser treatments to see which works better for women with hair loss on the top or front of the scalp. The lasers are non-invasive and aim to stimulate hair growth.
This study tests an experimental treatment called EPI-001 for androgenetic alopecia—the most common type of hair loss affecting men and women. Researchers will measure how well it works by tracking hair growth over time using special photography and scalp analysis.
Hear when a new Female Pattern Hair Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.